Content about Sandoz

August 26, 2010

The FDA approved Sandoz Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature,...

August 23, 2010

French drug maker Sanofi-Aventis is suing to stop Sandoz’ generic version of its blood thinner...

July 22, 2010

The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected...

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

 

The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

 

 

July 15, 2010

Sales and profits grew significantly for Swiss drug maker Novartis, with significant growth across divisions,...

July 13, 2010

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

NORTH WALES, Pa. Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said.

 

Teva announced the launch of naratriptan tablets in the 1 mg and 2.5-mg strengths. The tablets are a generic version of GlaxoSmithKline’s Amerge. The drug is used to treat acute migraine attacks in adults with or without visual disturbances preceding the attacks known as aura.

 

 

July 11, 2010

Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss...

PRINCETON, N.J. Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss drug maker Novartis said Monday.

 

Sandoz launched naratriptan hydrochloride tablets in the 2.5-mg strength, a generic version of GlaxoSmithKline’s Amerge. The tablets are used for treating acute migraine attacks in adults with or without visual disturbances that occur before the onset of the headache, also known as aura. Studies have indicated that around 12% of Americans have migraine attacks.

 

 

July 6, 2010

Sandoz has launched a version of a drug for treating dementia, the generics arm of...

June 29, 2010

Some of the strongest growth among large drug companies may come from Swiss drug maker...

June 28, 2010

Icelandic generic drug maker Actavis has appointed a new chief executive, Actavis said last week....

June 27, 2010

The Food and Drug Administrations has approved two new uses for what remains, thus far,...

June 10, 2010

Sandoz has opened what it calls a key site for the development of generic drugs...

June 2, 2010

Sandoz has acquired privately owned U.S. drug maker Oriel Therapeutics, the generics arm of Novartis...

May 19, 2010

Sandoz has launched a generic version of a muscle relaxant, the generics arm of Swiss...

May 16, 2010

Sandoz got its hands on a collection of generic drug candidates as it agreed to...

May 4, 2010

Sandoz has launched a generic antibiotic for pneumonia and acute sinus infections, the generics arm...

May 3, 2010

Sandoz has launched a generic version of a prostate drug, the generics arm of Novartis...

January 25, 2010

Daniel Vasella will step down as CEO of Novartis to focus on his position as...

January 25, 2010

Sandoz is “confident” that it will win approval for a generic anti-clotting drug, according to...

January 20, 2010

Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the...